Automating a 96-well microtiter plate assay for identification of AGEs inhibitors or inducers: application to the screening of a small natural compounds library

Derbré, Séverine; Gatto, Julia; Pelleray, Aude; Coulon, Laurie; Séraphin, Denis; Richomme, Pascal
October 2010
Analytical & Bioanalytical Chemistry;Oct2010, Vol. 398 Issue 4, p1747
Academic Journal
dvanced glycation end-products (AGEs) are involved in the pathogenesis of numerous affections such as diabetes and neurological diseases. AGEs are also implied in various changes in tissues and organs. Therefore, compounds able to break them or inhibit their formation may be considered as potential drugs, dietary supplements, or bioactive additives. In this study, we have developed a rapid and reliable ( Z′ factor calculation) anti-AGEs activity screening based on the overall fluorescence of AGEs. This method was successfully evaluated on known AGEs inhibitors and on a small library of natural compounds, yielding coherent results when compared with literature data.


Related Articles

  • Limitations of a Cosolvent for Ecotoxicity Testing of Hydrophobic Compounds. Bundy, J. G.; Maciel, H.; Cronin, M. T. D.; Paton, G. I. // Bulletin of Environmental Contamination & Toxicology;Jan2003, Vol. 70 Issue 1, p0001 

    The article cites a study on limitations of a cosolvent for ecotoxicity testing of hydrophobic compounds. Researchers applied simple quantitative structure-activity relationships to provide a testable hypothesis of the systematic effects of a cosolvent on a series of compounds in ecotoxicity...

  • bioactive.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p263 

    The definition of the term "bioactive," which refers to a substance that has an effect on the living tissue, is presented.

  • Once weekly exenatide vs sitagliptin or pioglitazone for type 2 diabetes. Kuritzky, Louis // Neurology Alert;Nov2010 Primary Care, p21 

    The article discusses a study on the test concerning exenatide, sitagliptin, and piolitazone as effective treatments for type 2 diabetes by R. M. Bergenstal et al. which appeared in the 2010 issue of "The Lancet."

  • Deep tissue two-photon microscopy. Helmchen, Fritjof; Denk, Winfried // Nature Methods;Dec2005, Vol. 2 Issue 12, p932 

    With few exceptions biological tissues strongly scatter light, making high-resolution deep imaging impossible for traditional—including confocal—fluorescence microscopy. Nonlinear optical microscopy, in particular two photon–excited fluorescence microscopy, has overcome this...

  • The NIA Interventions Testing Program Announces the 2013 Solicitation of Proposals.  // Journals of Gerontology Series A: Biological Sciences & Medical ;Aug2013, Vol. 68 Issue 8, p999 

    The article discusses a solicitation of proposals by the U.S. National Institute on Aging (NIA) in which suggested compounds are requested for the NIA's Interventions Testing Program (ITP).

  • A new predictor for type 2 diabetes? Sorisky, Alexander // CMAJ: Canadian Medical Association Journal;1/29/2008, Vol. 178 Issue 3, p313 

    The article reports on the research revealing the rising incidence of type 2 diabetes due to the increasing prevalence of obesity and the dysfunctional state of the adipose tissue associated with obesity. Researchers informs that adipose tissue actively manages complex energy exchanges and...

  • An Endophytic Sanguinarine-Producing Fungus from Macleaya cordata, Fusarium proliferatum BLH51. Wang, Xue-Jun; Min, Chang-Li; Ge, Mei; Zuo, Rui-Hua // Current Microbiology;Mar2014, Vol. 68 Issue 3, p336 

    Fermentation processes using sanguinarine-producing fungi other than Macleaya cordata may be an alternative way to produce sanguinarine (SA), which is a quaternary benzo[c]phenanthridine alkaloid possessing antibacterial, anthelmintic, and anti-inflammatory properties. In this study, a...

  • Expression and Purification of Bioactive High-Purity Recombinant Mouse CXCL14 in Escherichia coli. Li, Jingjing; Gao, Jin; Sah, Sunita; Satyal, Uttam; Zhang, Ruliang; Han, Wei; Yu, Yan // Applied Biochemistry & Biotechnology;Sep2011, Vol. 164 Issue 8, p1366 

    Mouse CXCL14/BRAK is a monocyte-selective chemokine which is expressed in almost all normal tissues. A flood of reports on its new functions of tumor suppression and fat metabolism modulation has left CXCL14 a potential therapeutic candidate for these diseases. Therefore, a simple accessible...

  • selectivity.  // Royal Society of Medicine: Medicines;2002, p490 

    This article presents information on the selectivity of drug action where at a given concentration a given drug acts preferentially on one receptor or tissue, and it helps minimize side-effects.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics